Synapsoft logo
AI Insights from Disclosures
Searching...
Hanmi Pharm. Co., Ltd. 128940
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
Hanmi Pharm. Co., Ltd. engages in the manufacture and sale of pharmaceuticals, and classifies each of its consolidated subsidiaries into one segment: pharmaceuticals, active pharmaceutical ingredients, or overseas pharmaceuticals. 1) In the pharmaceuticals segment, Hanmi Pharm. Co., Ltd.'s main business purpose is the manufacture and sale of pharmaceuticals, with major products including the combination hypertension treatment 'Amosartan', the combination hyperlipidemia treatment 'Rosuzet', the reflux esophagitis treatment 'Esomezol', the benign prostatic hyperplasia treatment 'Hanmi Tams Capsule', and the erectile dysfunction treatment 'Palpal Tablet'.
Representative Director Hwang Sangyeon
Founded July 5, 2010
Corporation Type KOSPI
Industry Classification Manufacture of synthetic drug and other finished medicaments
Corporate number 13481-0197550
Business number 124-87-00613
Phone Number 02-410-9114
Fax Number 02-410-9029
Website None
Company Address 214 Muha-ro, Paltan-myeon, Manse-gu, Hwaseong-si, Gyeonggi-do
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant